Search
Cancer is tough, no matter the age. But adolescents and young adults with cancer face a whole host of unique challenges, including delayed diagnoses. MSK created an Adolescent and Young Adult (AYA at MSK) program which unites experts across 16 specialties.
Childhood leukemia expert Melvyn Greaves received The Society of Memorial Sloan Kettering Prize at the 2018 Gerstner Sloan Kettering Graduate School of Biomedical Sciences (GSK) commencement.
Learn about a three-drug treatment that has been shown to extend survival for ER+, HER2- breast cancers.
Watch our scientists discuss how the Geoffrey Beene Center helped Memorial Sloan Kettering establish a progressive approach to modern cancer research.
Johanna Joyce, of the Sloan Kettering Institute's Cancer Biology and Genetics Program, has been named the first incumbent of a Geoffrey Beene Junior Faculty Chair.
Meet Ben Hegel, a senior program coordinator in the Sloan Kettering Institute. “My introduction to Pride in college was through a celebratory lens,” says Ben. “But my relationship to Pride has changed.” He still celebrates, but he points out that the Pride March is just that — a march, not a parade. “It was started by marginalized people who were marching for their rights.”
Memorial Sloan Kettering Cancer Center (MSK) is accepting applications for the 2025 Cohort of the MSK Innovation Hub (iHub) Challenge program. Digital health companies with innovations leveraging AI to address critical issues in the drug discovery process are encouraged to apply.
A new treatment that selectively seeks out prostate cancer cells shows great promise for treating advanced forms of the disease.
Meet Cesar Figueroa Ortiz, who says, “The mission of MSK really resonated with me, all the employees seemed very happy, and the patients said great things about their care.”